Literature DB >> 10780924

Construction and in vitro analysis of a new bi-modular polypeptide synthetase for synthesis of N-methylated acyl peptides.

F Schauwecker1, F Pfennig, N Grammel, U Keller.   

Abstract

BACKGROUND: Many active peptides are synthesized by nonribosomal peptide synthetases (NRPSs), large multimodular enzymes. Each module incorporates one amino acid, and is composed of two domains: an activation domain that activates the substrate amino acid and a condensation domain for peptide-bond formation. Activation domains sometimes contain additional activities (e.g. N-methylation or epimerization). Novel peptides can be generated by swapping domains. Exchange of domains containing N-methylation activity has not been reported, however.
RESULTS: The actinomycin NRPS was used to investigate domain swapping. The first two amino acids of actinomycin are threonine and valine. We replaced the valine activation domain of module 2 with an N-methyl valine (MeVal) activation domain. The recombinant NRPS (AcmTmVe) catalyzes the formation of threonyl-valine. In the presence of S-adenosyl-methionine, valine was converted to MeVal but subsequent dipeptide formation was blocked. When acyl-threonine (the natural intermediate) was present at module 1, formation of acyl-threonine-MeVal occurred. The epimerization domain of AcmTmVe was impaired.
CONCLUSIONS: A simple activation domain can be replaced by one with N-methylation activity. The same condensation domain can catalyze peptide-bond formation between N-methyl and nonmethylated amino acids. Modification of the upstream amino acid (i.e. acylation of threonine), however, was required for condensation with MeVal. Steric hindrance reduces chemical reactivity of N-methyl amino acids - perfect substrate positioning may only be achieved with acylated threonine. Loss of the epimerase activity of AcmTmVe suggests N-methyltransferase and epimerase domains, not found together naturally, are incompatible.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10780924     DOI: 10.1016/s1074-5521(00)00103-4

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  7 in total

1.  Directed evolution can rapidly improve the activity of chimeric assembly-line enzymes.

Authors:  Michael A Fischbach; Jonathan R Lai; Eric D Roche; Christopher T Walsh; David R Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-09       Impact factor: 11.205

Review 2.  Nonribosomal peptide synthetases involved in the production of medically relevant natural products.

Authors:  Elizabeth A Felnagle; Emily E Jackson; Yolande A Chan; Angela M Podevels; Andrew D Berti; Matthew D McMahon; Michael G Thomas
Journal:  Mol Pharm       Date:  2008-01-25       Impact factor: 4.939

Review 3.  Structural insights into nonribosomal peptide enzymatic assembly lines.

Authors:  Alexander Koglin; Christopher T Walsh
Journal:  Nat Prod Rep       Date:  2009-05-22       Impact factor: 13.423

4.  The actinomycin biosynthetic gene cluster of Streptomyces chrysomallus: a genetic hall of mirrors for synthesis of a molecule with mirror symmetry.

Authors:  Ullrich Keller; Manuel Lang; Ivana Crnovcic; Frank Pfennig; Florian Schauwecker
Journal:  J Bacteriol       Date:  2010-03-19       Impact factor: 3.490

Review 5.  Harnessing natural product assembly lines: structure, promiscuity, and engineering.

Authors:  Christopher C Ladner; Gavin J Williams
Journal:  J Ind Microbiol Biotechnol       Date:  2015-11-02       Impact factor: 3.346

Review 6.  Chemoenzymatic and template-directed synthesis of bioactive macrocyclic peptides.

Authors:  Jan Grünewald; Mohamed A Marahiel
Journal:  Microbiol Mol Biol Rev       Date:  2006-03       Impact factor: 11.056

7.  Genetic interrelations in the actinomycin biosynthetic gene clusters of Streptomyces antibioticus IMRU 3720 and Streptomyces chrysomallus ATCC11523, producers of actinomycin X and actinomycin C.

Authors:  Ivana Crnovčić; Christian Rückert; Siamak Semsary; Manuel Lang; Jörn Kalinowski; Ullrich Keller
Journal:  Adv Appl Bioinform Chem       Date:  2017-04-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.